• Asia-Pacific flu market to hit $1.71bn by 2022 pharmafile
    January 22, 2017
    According to new data from intelligence provider GBI Research, the flu vaccines market in the Asia-Pacific (APAC) region is set to grow from $1.24 billion in 2015 to more than $1.71 billion in 2022.
PharmaSources Customer Service